Inclusion criteria for the review were clearly defined and several relevant data sources were searched. Articles in English, French or German were considered, although there could still be some risk for language bias. There was a low risk of publication bias. Attempts were made to reduce reviewer error and bias during the review.
Quality assessment was undertaken using a standard checklist, which indicated that the quality of the included studies was fair to good. Data were combined using meta-analysis and statistical heterogeneity was assessed, which was appropriate. The authors noted that the included studies did not describe concomitant medication usage, which may have confounded the results. Many outcomes could not be quantitatively pooled, which hindered interpretation of the results. The clinical significance of the outcomes was also not mentioned, and the justification for using standardised mean differences over weighted mean differences was not given.
Overall, the authors’ conclusions were based on the evidence and appear reasonable, although the fact that many outcomes could not be pooled and the uncertain clinical significance of outcomes should be considered.